nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.08.2006 | Controversies

Is PET/CT necessary in paediatric oncology?

verfasst von: Christiane Franzius, Kai Uwe Juergens, Otmar Schober

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Excerpt

The introduction of combined PET/CT into clinical practice has been greeted with much enthusiasm among nuclear medicine physicians, radiologists and oncologists. Since the first PET/CT scanners became available, many studies have demonstrated its clinical value in various tumour types (reviews in [1, 2]). The value of PET/CT in paediatric patients, however, has not been established. Case reports, pictorial essays and reports on feasibility and practical aspects have been published, but to date no studies have evaluated the diagnostic benefit of PET/CT in children [3‐6]. A limited number of studies have evaluated the clinical usefulness of (FDG-)PET as a single modality in paediatric tumour entities. The need for such studies has been stressed by many authors [3, 6‐8]. Nevertheless, it can already be anticipated that the combination of structural and metabolic information provided by integrated PET/CT will improve the accuracy of staging and will have the potential to change management in a significant number of paediatric patients, as has been demonstrated in adults (reviews in [2, 9‐11]). …

Czernin J, Auerbach MA. Clinical PET/CT imaging. Nuklearmedizin 2005;44:18–23.

Wechalekar K, Sharma B, Cook G. PET/CT in oncology—a major advance. Clin Radiol 2005;60:1143–55.PubMedCrossRef

Kaste S. Issues specific to implementing PET-CT for pediatric oncology: what have we learned along the way? Pediatr Radiol 2004;34:205–13.PubMedCrossRef

McCarville MB, Christie R, Daw NC, Spunt SL, Kaste SC. PET/CT in evaluation of childhood sarcomas. Am J Roentgenol 2005;184:1293–304.

Franzius C, Juergens KU, Vormoor J. PET/CT with diagnostic CT in the evaluation of childhood sarcoma. Am J Roentgenol 2006;186:581.CrossRef

Franzius C, Lang K, Wormanns D, Vormoor J, Schober O. PET/CT and PET—application in pediatric oncology. Der Nuklearmediziner 2004;27:315–323

Herrmann S, Wormanns D, Pixberg M, Hunold A, Heindel WL, Jürgens H, et al. Staging in childhood lymphoma: differences between FDG-PET and CT. Nuklearmedizin 2005;44:1–7.

Körholz D, Clavies A, Hasenclever D, Kluge R, Hirsch W, Kamprad F, et al. The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin’s disease: evolution in the tradition of DAL/GPOH studies. Klin Pädiatr 2004;216:150–6.PubMedCrossRef

Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003;44:1200–9.PubMed

10.

Yeung HWD, Schröder H, Smith A, Gonen M, Larson SML. Clinical value of combined positron emission tomography/computed tomography imaging in the interpretation of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography studies in cancer patients. Mol Imaging Biol 2005;7:229–35.PubMedCrossRef

11.

Blodgett TM, Casagranda B, Townsend DW, Meltzer CC. Issues, controversies, and clinical utility of combined PET/CT imaging: what is the interpreting physician facing? Am J Roentgenol 2005;184:138–45.

12.

Brenner DJ, Elliston CD, Hall EJ, Berdon WE. Estimated risks of radiation-induced fatal cancer from pediatric CT. Am J Roentgenol 2001;176:286–96.

13.

Honnef D, Wildberger JE, Stargardt A, Hohl C, Barker M, Günther RW, et al. Multislice spiral CT (MSCT) in pediatric radiology: dose reduction for chest and abdomen examinations. Fortschr Röntgenstr 2004;176:1021–30.CrossRef

14.

Lang K, Vormoor J, Weckesser M, Schober O, Franzius C. PET-CT in pediatric patients: analysis of 175 whole body scans. Eur J Nucl Med Mol Imaging 2005;32 Suppl 1:154.

15.

Messa C, Bettinardi V, Picchio M, Pelosi E, Landoni C, Gianolli L, et al. PET/CT in diagnostic oncology. Q J Nucl Med 2004;48:75–86.

16.

Osman MM, Cohade C, Fishman EK, Wahl RL. Clinically significant incidental findings on the unenhanced CT portion of PET/CT studies: frequency in 250 patients. J Nucl Med 2005;46:1352–5.PubMed

17.

Coleman RE, Delbeke D, Guiberteau MJ, Conti PS, Royal H, Weinreb JC, et al. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Nucl Med 2005;46:1225–39.PubMed

18.

Kuehl H, Antoch G. How much CT do we need for PET/CT? Nuklearmedizin 2005;44:24–31.

19.

Paterson A, Frush DP, Donnelly LF. Helical CT of the body: are settings adjusted for pediatric patients? Am J Roentgenol 2001;176:297–301.

20.

Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I, et al. A radiopharmaceutical schedule for image in pediatric. Recommendations of the Pediatric Task Group of the European Association of Nuclear Medicine. Eur J Nucl Med 1990;17:127–9.PubMedCrossRef

21.

Hahn K, Fischer S. Radiation dose and radiation protection from paediatric nuclear medicine procedures. Der Nuklearmediziner 2002;25:90–100.CrossRef

22.

Bundesamt für Strahlenschutz. Bekanntmachung der diagnostischen Referenzwerte für radiologische und nuklearmedizinische Untersuchungen. BAnz;Nr. 143 vom 05.08.2003.

23.

Noßke D, Minkow V, Brix G. Establishment and application of diagnostic reference levels for nuclear medicine procedure in Germany. Nuklearmedizin 2004;43:79–84.PubMed

24.

Frush DP, Donnelly LF, Rosen NS. Computed tomography and radiation risk: what pediatric health care providers should know. Pediatrics 2003;112:951–7.PubMedCrossRef

25.

Pages J, Buls N, Osteau M. CT doses in children: a multicentre study. Br J Radiol 2003;76:803–11.PubMedCrossRef

26.

Wildberger JE, Mahnken AH, Schmitz-Rode T, Flohr T, Stargardt A, Haage P, et al. Individually adapted examination protocols for reduction of radiation exposure in chest CT. Invest Radiol 2001;10:604–11.CrossRef

27.

Yekeler E. Pediatric abdominal applications of multidetector-row CT. Eur J Radiol 2004;52:31–43.PubMedCrossRef

28.

Wormanns D, Diederich S, Lenzen H, Lange P, Link TM, Ludwig K, et al. Abdominal spiral CT in children: which radiation exposure is required? Eur Radiol 2001;11:2262–6.PubMedCrossRef

29.

Nickoloff EL, Dutta AK, Lu ZF. Influence of phantom diameter, kVp and scan mode upon computed tomography dose index. Med Phys 2003;30:395–402.PubMedCrossRef

30.

Kalender WA, Wolf H, Suess C. Dose reduction in CT by anatomically adapted tube current modulation. II. Phantom measurements. Med Phys 1999;26:2248–53.PubMedCrossRef

31.

Rogalla P, Stöver B, Scheer I, Juran R, Gaedicke G, Hamm B. Low-dose spiral CT: application to paediatric chest imaging. Pediatr Radiol 1999;29:565–9.PubMedCrossRef

32.

Weingaertner U, Lorenzen M, Nagel HD, Weber C, Adam G. Diagnostic imaging in polytrauma: comparison of radiation exposure from whole-body MSCT and conventional radiography with organ-specific CT. Fortschr Röntgenstr 2004;176:1039–44.CrossRef

33.

Chan FP, Rubin GD. MDCT angiography of pediatric vascular disease of the abdomen, pelvis, and extremities. Pediatr Radiol 2005;35:40–53.PubMedCrossRef

34.

Wu TH, Huang YH, Lee JJS, Wang SY, Wang SC, Su CT, et al. Radiation exposure during transmission measurements: comparison between CT- and germanium-based techniques with a current PET scanner. Eur J Nucl Med Mol Imaging 2004;31:38–43.PubMedCrossRef

35.

Wu TH, Chu TC, Huang YH, Chen LK, Mok SP, Lee JK, et al. A positron emission tomography/computed tomography (PET/CT) acquisition protocol for CT radiation dose optimization. Nucl Med Commun 2005;26:323–30.PubMedCrossRef

36.

Brianzoni E, Rossi G, Ancidei S, Berbellini A, Capocetti F, Cidda C, et al. Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clincal target volume. Eur J Nucl Med Mol Imaging 2005;32:1392–9.PubMedCrossRef

37.

Weckesser M, Konemann S, Brinkmann M, Willich N, Schober O. PET/CT in radiotherapy. Radiologe 2004;44:1096–104.PubMedCrossRef

38.

Slomka PJ, Dey D, Przetak C, Aladl UE, Baum RP. Automated 3-dimensional registration of stand-alone F-18-FDG whole body PET with CT. J Nucl Med 2003;44:1156–67.PubMed

39.

Nakamoto Y, Cohade C, Tatsumi M, Hammoud D, Wahl RL. CT appearance of bone meastases detected with FDG PET as part of the same PET/CT examination. Radiology 2005;237:627–34.PubMedCrossRef

40.

Franzius C, Daldrup-Link HE, Sciuk J, Rummeny EJ, Bielack S, Jürgens H, et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 2001;12:479–86.PubMedCrossRef

41.

Kaste SC, Howard SC, McCarville EB, Krasin MJ, Kogos PG, Hudson MM.¹⁸F-FDG-avid sites mimicking active disease in pediatric Hodgkin’s. Pediatr Radiol 2004;35:141–54.PubMedCrossRef

42.

Franzius C, Lang K, Vormoor J, Weckesser M, Schober O. Whole body PET-CT with C-11-meta-hydroxyephedrine (C-11-HED) in tumors of the sympathetic nervous system: comparison with I-123-mIBG SPECT. Eur J Nucl Med Mol Imaging 2005;32 Suppl 1:54.

43.

Serafini G, Ongaro L, Mori A, Rossi C, Cavalloro F, Tagliaferri C, et al. Anesthesia for MRI in the pediatric patient. Minerva Anestesiol 2005;71:361–6.PubMed

44.

Coté CJ, Karl HW, Notterman DA. Adverse sedation events in pediatrics: analysis of medications used for sedation. Pediatrics 2000;106:633–44.PubMedCrossRef

45.

Franzius C, Sciuk J, Brinkschmidt C, Jürgens H, Schober O. Evaluation of chemotherapy response in primary bone tumors with F-18-FDG-PET compared with histologically assessed tumor necrosis. Clin Nucl Med 2000;25:874–81.PubMedCrossRef

46.

Franzius C, Daldrup-Link HE, Wagner-Bohn A, Sciuk J, Heindel WL, Jürgens H, et al. FDG PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Ann Oncol 2002;13:157–60.PubMedCrossRef

47.

Lucas JD, O’Doherty MJ, Wong JCH, Bingham JB, McKee PH, Fletcher CDM, et al. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcoma. J Bone Joint Surg (Br) 1998;80-B:441–7.CrossRef

48.

Lucas JD, O’Doherty MJ, Cronin BF, Marsden PK, Lodge MA, McKee PH, et al. Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography. Br J Surg 1999;86:550–6.PubMedCrossRef

49.

Hawkins DS, Rajendran JG, Conrad EU, Bruckner JD, Eary JF. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography. Cancer 2002;94:3277–84.PubMedCrossRef

50.

Montravers F, McNamara D, Landman-Parker J, Grahek D, Kerrou K, Younsi N, et al. [F-18]FDG in childhood lymphoma: clinical utility and impact on management. Eur J Nucl Med Mol Imaging 2002;29:1155–65.PubMedCrossRef

51.

Hudson MM, Krasin MJ, Kaste SC. PET imaging in pediatric Hodgkin’s lymphoma. Pediatr Radiol 2004;34:190–8.PubMedCrossRef

52.

Tatsumi M, Cohade C, Nakamato Y, Fishman EK, Wahl RL. Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience. Radiology 2005;237:1038–45.PubMedCrossRef

53.

Krasin MJ, Hudson MM, Kaste SC. Positron emission tomography in pediatric radiation oncology: integration in the treatment-planning process. Pediatr Radiol 2004;34:214–21.PubMedCrossRef

Titel: Is PET/CT necessary in paediatric oncology?
verfasst von: Christiane Franzius
Kai Uwe Juergens
Otmar Schober
Publikationsdatum: 01.08.2006
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 8/2006
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-006-0114-6

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2006

Is PET/CT necessary in paediatric oncology?

Simplified quantification of small animal [18F]FDG PET studies using a standard arterial input function

Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states

Disease activity and 18F-FDG uptake in organising pneumonia: semi-quantitative evaluation using computed tomography and positron emission tomography

Imaging of adrenocortical metastases with [11C]metomidate

Quantitation of cardiac sympathetic innervation in rabbits using 11C-hydroxyephedrine PET: relation to 123I-MIBG uptake